申请人:Janssen Pharmaceutica NV
公开号:US20210147446A1
公开(公告)日:2021-05-20
Pyrazolopyridinone compounds, the pharmaceutical compositions comprising said compounds, and the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and their use in the treatment of diseases, e.g. cancer.